Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other


Clarus Lifesciences III, L.P. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/22/2020 4 Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 4 on Praxis Precision Medicines, Inc.
Txns: Converted 3,446,711 shares @ $0
Converted 2,361,198 shares @ $0
Converted 659,116 shares @ $0
Converted 261,318 shares @ $0
Converted 907,378 shares @ $0
Converted 164,832 shares @ $0
Converted 7,375,799 options to buy @ $0
Converted 5,052,852 options to buy @ $0
Converted 1,410,477 options to buy @ $0
Converted 559,208 options to buy @ $0
Converted 1,941,748 options to buy @ $0
10/15/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
10/01/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
10/01/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/25/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
07/30/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/23/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
07/09/2020 SC 13D/A Clarus Lifesciences III, L.P. reports a 4.9% stake in Entasis Therapeutics Holdings Inc.
05/01/2020 SC 13D/A Clarus Lifesciences III, L.P. reports a 11.1% stake in Entasis Therapeutics Holdings Inc.
09/06/2019 SC 13D/A Clarus Lifesciences III, L.P. reports a 16.7% stake in ESSA PHARMA INC.
08/05/2019 SC 13D/A Clarus Lifesciences III, L.P. reports a 0% stake in AVROBIO, Inc.
05/22/2019 4 Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 4 on AVROBIO, Inc.
Txns: Disposed of 1,481,163 shares @ $0
10/12/2018 SC 13D Clarus Lifesciences III, L.P. reports a 8.9% stake in Gritstone Oncology, Inc.
10/09/2018 SC 13D Clarus Lifesciences III, L.P. reports a 12.4% stake in Entasis Therapeutics Holdings Inc.
10/02/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/02/2018 4 Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 4 on Gritstone Oncology, Inc.
Txns: Bought 333,333 shares @ $15, valued at $5M
Converted 2,234,112 shares @ $0
Converted 1,565,216 convertible preferred @ $0
Converted 668,896 convertible preferred @ $0
09/27/2018 3 Form 3 - Initial statement of beneficial ownership of securities:
09/25/2018 3 Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 3 on Entasis Therapeutics Holdings Inc.
07/12/2018 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
07/05/2018 SC 13D Clarus Lifesciences III, L.P. reports a 12.8% stake in Avrobio, Inc.
07/02/2018 4 Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 4 on Forty Seven, Inc.
Txns: Converted 938,489 shares @ $0
Converted 755,780 shares @ $0
Converted 1,922,682 shares @ $0
Bought 200,000 shares @ $16, valued at $3.2M
Converted 938,489 preferred shares @ $0
Converted 755,780 preferred shares @ $0
Converted 1,922,682 preferred shares @ $0
06/27/2018 3 Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 3 on Forty Seven, Inc.
06/25/2018 4 Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 4 on AVROBIO, Inc.
Txns: Converted 2,283,434 shares @ $0
Converted 678,891 shares @ $0
Converted 9,435,150 preferred shares @ $0
Converted 2,805,179 preferred shares @ $0
06/20/2018 3 Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 3 on AVROBIO, Inc.
06/19/2018 SC 13D/A Clarus Lifesciences III, L.P. reports a 30.2% stake in ESSA PHARMA INC.
02/09/2016 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/25/2016 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
02/13/2015 SC 13G Clarus Lifesciences III, L.P. reports a 7.9% stake in Neothetics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy